Protocol CY 5021: A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients with Spinal Muscular Atrophy (SMA)

Project: Research project

Project Details

Effective start/end date1/16/181/16/21


  • Ann & Robert H. Lurie Children’s Hospital of Chicago (Protocol CY 5021 // Protocol CY 5021)
  • Cytokinetics, Inc. (Protocol CY 5021 // Protocol CY 5021)